Matches in SemOpenAlex for { <https://semopenalex.org/work/W2147502668> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2147502668 endingPage "67" @default.
- W2147502668 startingPage "67" @default.
- W2147502668 abstract "The cystic fibrosis gene encodes the cystic fibrosis transmembrane conductance regulator (CFTR) protein whicha is a 1480 amino acid, glycosylated membrane protein that functions as a cAMP-dependent chloride (Cl−) channel. It is mainly expressed in secretory epithelia. The F508del-CFTR protein, resultant from the mutant gene found in 70% of CF chromosomes, is aberrantly folded, mostly blocked for maturation and degraded in the ER by the ubiquitin proteosome pathway. This mutant still functions as a cAMP-dependent Cl− channel to some degree if the protein is directed to the plasma membrane by some strategy that corrects its cellular location. The properties of wild-type and mutant CFTR proteins are studied extensively using different biochemical and biophysical approaches. Although these studies are being developed for more than 15 years, many dark areas in the research field of CFTR protein still need to be unmasked. For example, the production of specific anti-CFTR antibodies was one of the main problems for Western immunoprecipitation and immunocytochemistry experiments. Today, the evaluation of existing antibodies shows that only few anti-CFTR antibodies are suitable for native tissue analysis, but several can be used for cell line experiments. The applicability of existing anti-CFTR antibodies is discussed here [[1]Mendes F. Farinha C.M. Roxo-Rosa M. Fanen P. Edelman A. Dormer R.L. et al.Antibodies for CFTR studies.J. Cyst. Fibros. 2004; 3: 69-72Abstract Full Text Full Text PDF PubMed Scopus (35) Google Scholar], as well as the basic biochemical techniques that are currently used for the study of CFTR protein produced in vivo [[2]Farinha C.M. Penque D. Roxo-Rosa M. Lukacs G. Dormer R.L. McPherson M. et al.Biochemical methods to assess CFTR expression and membrane localization.J. Cyst. Fibros. 2004; 3: 73-77Abstract Full Text Full Text PDF PubMed Scopus (45) Google Scholar] and the techniques for its in vitro study [[3]Benos D.J. Berdiev B.K. Ismailov I.I. Ostedgaard L. Kogan I. Li C. et al.Methods to study CFTR protein in vitro.J. Cyst. Fibros. 2004; 3: 79-83Abstract Full Text Full Text PDF PubMed Scopus (6) Google Scholar]. New studies based on proteomic approaches are reviewed here [[4]Roxo-Rosa M. Davezac N. Bensalem N. Majumder M. Heda G.D. Simas A. et al.Proteomics techniques for cystic fibrosis research.J. Cyst. Fibros. 2004; 3: 85-89Abstract Full Text Full Text PDF PubMed Scopus (16) Google Scholar]. These are being developed to get insights on proteins differentially expressed in CF versus non-CF cells/tissues or on proteins interacting with CFTR/F508del-CFTR that may be involved in the traffic/degradation and or activity of CFTR/F508del-CFTR. The recent elucidation of murine CFTR nucleotide binding domain 1 (NBD1) called for a discussion and review of the CFTR structural aspects [[5]Dorwart M. Thibodeau P. Thomas P. Cystic fibrosis: recent structural insights.J. Cyst. Fibros. 2004; 3: 91-94Abstract Full Text Full Text PDF PubMed Scopus (12) Google Scholar]. The role of normal and mutant CFTR on the glycosylation pattern of other proteins and its consequences for host–bacterial interactions in the light of recently published data are also discussed in this section [[6]Rhim A.D. Stoykova L.I. Trindade A.J. Glick M.C. Scanlin T.F. Altered terminal glycosylation and the pathophysiology of CF lung disease.J. Cyst. Fibros. 2004; 3: 95-96Abstract Full Text Full Text PDF PubMed Scopus (21) Google Scholar]. Novel insights on lipidic alterations in CF and possible consequences for CF deserve our attention and are also reported from a methodological point of view [[7]Ollero M. Methods for the study of lipid metabolites in cystic fibrosis.J. Cyst. Fibros. 2004; 3: 97-98Abstract Full Text Full Text PDF PubMed Scopus (3) Google Scholar]. We believe that we were able to gather in this section (often as authors in one joint manuscript) key groups in each subarea dealt with. All articles are outlines/reviews of various protocols available at the European Working Group on CFTR Expression website [[8]European Working Group on CFTR ExpressionThe Online Virtual Repository of Methods and Reagents for CFTR Expression and Functional Studies (section C).2004Google Scholar] that should be used extensively as supplementary material. Our aim was to provide a series of methodologies that hopefully will be useful to the novice and experienced researcher alike by reducing effort and research time of all with an interest in this field." @default.
- W2147502668 created "2016-06-24" @default.
- W2147502668 creator A5014956829 @default.
- W2147502668 creator A5082884953 @default.
- W2147502668 date "2004-08-01" @default.
- W2147502668 modified "2023-09-26" @default.
- W2147502668 title "General introduction to section C: Biochemistry and Biophysics of CFTR" @default.
- W2147502668 cites W1983985415 @default.
- W2147502668 cites W1986541049 @default.
- W2147502668 cites W2033134846 @default.
- W2147502668 cites W2097063987 @default.
- W2147502668 cites W2123401085 @default.
- W2147502668 cites W2141333146 @default.
- W2147502668 cites W2170305758 @default.
- W2147502668 doi "https://doi.org/10.1016/j.jcf.2004.05.015" @default.
- W2147502668 hasPublicationYear "2004" @default.
- W2147502668 type Work @default.
- W2147502668 sameAs 2147502668 @default.
- W2147502668 citedByCount "0" @default.
- W2147502668 crossrefType "journal-article" @default.
- W2147502668 hasAuthorship W2147502668A5014956829 @default.
- W2147502668 hasAuthorship W2147502668A5082884953 @default.
- W2147502668 hasBestOaLocation W21475026681 @default.
- W2147502668 hasConcept C104317684 @default.
- W2147502668 hasConcept C134018914 @default.
- W2147502668 hasConcept C143065580 @default.
- W2147502668 hasConcept C144647389 @default.
- W2147502668 hasConcept C145822097 @default.
- W2147502668 hasConcept C153911025 @default.
- W2147502668 hasConcept C159654299 @default.
- W2147502668 hasConcept C170493617 @default.
- W2147502668 hasConcept C203014093 @default.
- W2147502668 hasConcept C24530287 @default.
- W2147502668 hasConcept C2776938444 @default.
- W2147502668 hasConcept C2778428886 @default.
- W2147502668 hasConcept C2779926675 @default.
- W2147502668 hasConcept C35866371 @default.
- W2147502668 hasConcept C41625074 @default.
- W2147502668 hasConcept C54355233 @default.
- W2147502668 hasConcept C55493867 @default.
- W2147502668 hasConcept C71829478 @default.
- W2147502668 hasConcept C86803240 @default.
- W2147502668 hasConcept C95444343 @default.
- W2147502668 hasConceptScore W2147502668C104317684 @default.
- W2147502668 hasConceptScore W2147502668C134018914 @default.
- W2147502668 hasConceptScore W2147502668C143065580 @default.
- W2147502668 hasConceptScore W2147502668C144647389 @default.
- W2147502668 hasConceptScore W2147502668C145822097 @default.
- W2147502668 hasConceptScore W2147502668C153911025 @default.
- W2147502668 hasConceptScore W2147502668C159654299 @default.
- W2147502668 hasConceptScore W2147502668C170493617 @default.
- W2147502668 hasConceptScore W2147502668C203014093 @default.
- W2147502668 hasConceptScore W2147502668C24530287 @default.
- W2147502668 hasConceptScore W2147502668C2776938444 @default.
- W2147502668 hasConceptScore W2147502668C2778428886 @default.
- W2147502668 hasConceptScore W2147502668C2779926675 @default.
- W2147502668 hasConceptScore W2147502668C35866371 @default.
- W2147502668 hasConceptScore W2147502668C41625074 @default.
- W2147502668 hasConceptScore W2147502668C54355233 @default.
- W2147502668 hasConceptScore W2147502668C55493867 @default.
- W2147502668 hasConceptScore W2147502668C71829478 @default.
- W2147502668 hasConceptScore W2147502668C86803240 @default.
- W2147502668 hasConceptScore W2147502668C95444343 @default.
- W2147502668 hasLocation W21475026681 @default.
- W2147502668 hasOpenAccess W2147502668 @default.
- W2147502668 hasPrimaryLocation W21475026681 @default.
- W2147502668 hasRelatedWork W1968164965 @default.
- W2147502668 hasRelatedWork W2055824725 @default.
- W2147502668 hasRelatedWork W2079902597 @default.
- W2147502668 hasRelatedWork W2088414254 @default.
- W2147502668 hasRelatedWork W2097868122 @default.
- W2147502668 hasRelatedWork W2101881248 @default.
- W2147502668 hasRelatedWork W2113074631 @default.
- W2147502668 hasRelatedWork W2147502668 @default.
- W2147502668 hasRelatedWork W2531669199 @default.
- W2147502668 hasRelatedWork W4244049418 @default.
- W2147502668 hasVolume "3" @default.
- W2147502668 isParatext "false" @default.
- W2147502668 isRetracted "false" @default.
- W2147502668 magId "2147502668" @default.
- W2147502668 workType "article" @default.